The researchers observed 331 patients who received small doses of the study drug or a placebo. No treatment-related serious adverse effects were reported in either diclofenac dose group, whereas only one was reported in the kerorolac group.
For patients with acute moderate and severe pain after abdominal or pelvic surgery, repeated lower doses of solubilized diclofenac provided significant analgesic efficacy, as compared with the placebo. It significantly reduced the need for opioids.
More Articles on Anesthesia:
MedNet Hires Anesthesiologist Dr. Brian Waltmann as Medical Director
General Anesthesia May Increase Blood Transfusions for Bilateral Knee Replacements
Somnia’s Anesthesia Evaluation App Now Available in Apple Store
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
